Synthesize Bio
Virtual Human Modeling for Clinical Trials
- Business Model
- B2B
- Website
- synthesize.bio
- Total Funding
- $10.0M
- Last Round
- $10.0M SeedSep 2025
- Rounds
- 1
About
AI-powered virtual human modeling platform that predicts gene expression and tissue responses to drugs for clinical trial optimization.
Summary
Synthesize Bio is an Artificial Intelligence company. It has raised $10.0M in total across 1 round, most recently a $10.0M Seed round in Sep 2025.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Sep 2025
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
Global fertility clinics platform
Specialty pharmaceutical company
Biopharmaceutical services company